Comparing High LET <sup>227</sup>Th- and Low LET <sup>177</sup>Lu-trastuzumab in Mice with HER-2 Positive SKBR-3 Xenografts-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparing High LET ²²⁷Th- and Low LET ¹⁷⁷Lu-trastuzumab in Mice with HER-2 Positive SKBR-3 Xenografts

Published:2013-06-01 Issue:2 Volume:6 Page:78-86
ISSN:1874-4710
Container-title:Current Radiopharmaceuticals
language:en
Short-container-title:CRP

Author:

Abbas Nasir,Heyerdahl Helen,Bruland Oyvind,Brevik Ellen,Dahle Jostein

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Radiology Nuclear Medicine and imaging

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 131I-Labeled Anti-HER2 Nanobody for Targeted Radionuclide Therapy of HER2-Positive Breast Cancer;International Journal of Nanomedicine;2023-04

2. Review of current status of targeted alpha therapy in cancer treatment;Nuclear Medicine Review;2023-02-16

3. Targeted thorium-227 conjugates as treatment options in oncology;Frontiers in Medicine;2023-01-09

4. ICRU REPORT 96, Dosimetry-Guided Radiopharmaceutical Therapy;Journal of the ICRU;2021-12

5. Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”;Pharmaceutics;2021-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP